Home › Funds › Callodine Capital Management, LP › BTI
Callodine Capital Management, LP position in BTI
Brit Amern Tob Plc Sponsored C · Health Care
Callodine Capital Management, LP reported holding 1,958,107 shares of BTI (Brit Amern Tob Plc Sponsored C) in its Q3 2026 13F filing — a position valued at US$106.5M, representing 6.83% of its reported portfolio and ranking #3 among its reported holdings. Callodine Capital Management, LP has disclosed BTI holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Callodine Capital Management, LP's BTI position evolved
Callodine Capital Management, LP first disclosed a stake in BTI in Q2 2025 at 527,500 shares (US$25.0M). The position peaked in Q3 2026 at 1,958,107 shares, worth US$106.5M. Across 6 filings, Callodine Capital Management, LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,958,107 shares valued at US$106.5M — an increase of 949,498 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2026 (shares rose 6% over the following quarter), a 94% increase in Q3 2026 (shares rose 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 527.50K | $24.97M | New |
| Q3 2025 | 607.80K | $32.26M | Add |
| Q4 2025 | 680.38K | $38.52M | Add |
| Q1 2026 | 1.08M | $63.00M | Add |
| Q2 2026 | 1.01M | $62.29M | Reduce |
| Q3 2026 | 1.96M | $106.52M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BTI and 13F data
BTI (Brit Amern Tob Plc Sponsored C) is a Health Care company. 34 other funds we track also report a position in BTI — the largest reported positions include Capital International Investors (US$2.66B), Orbis Allan Gray Ltd (US$456.1M), Mondrian Investment Partners LTD (US$237.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BTI
- Capital International Investors 48.93M sh · $2.66B · Q3 2026
- Orbis Allan Gray Ltd 7.39M sh · $456.12M · Q2 2026
- Mondrian Investment Partners LTD 4.36M sh · $237.05M · Q3 2026
- Marshall Wace 3.27M sh · $202.01M · Q2 2026
- Newport Trust Company, LLC 2.49M sh · $135.41M · Q3 2026
- Maple Rock Capital Partners Inc. 2.17M sh · $133.77M · Q2 2026
- Cullen Capital Management, LLC 2.43M sh · $132.26M · Q3 2026
- Empyrean Capital Partners, LP 1.93M sh · $118.89M · Q2 2026
- Capital International, Inc./CA/ 1.66M sh · $90.17M · Q3 2026
More on Callodine Capital Management, LP
FAQ
How long has Callodine Capital Management, LP held BTI?
Callodine Capital Management, LP has disclosed BTI holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Callodine Capital Management, LP's current position in BTI?
As of Q3 2026, Callodine Capital Management, LP holds 1.96M shares of BTI (Brit Amern Tob Plc Sponsored C), valued at $106.52M, representing 6.83% of its reported portfolio and ranking #3.
Has Callodine Capital Management, LP been buying or selling BTI?
In the latest 13F filing (Q3 2026), Callodine Capital Management, LP increased its position in BTI. The position peaked in Q3 2026 at 1.96M shares.
Which other funds hold BTI?
Other major institutional holders of BTI include Capital International Investors, Orbis Allan Gray Ltd, Mondrian Investment Partners LTD, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.